Maxipime and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxipime (cefepime hydrochloride) and Lenalidomide (lenalidomide). Common drug interactions include cytomegalovirus infection among females and neutrophil count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Maxipime and Lenalidomide. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

On Jul, 12, 2026

22 people who take Maxipime and Lenalidomide together, and have interactions are studied.

Maxipime and Lenalidomide drug interactions.

What are the common drug interactions of Maxipime and Lenalidomide, by gender? *:

female:

Cytomegalovirus infection
Epstein-barr virus associated lymphoproliferative disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus)
Pneumonia
Malignant neoplasm progression (cancer tumour came back)
Pyrexia (fever)
Diarrhoea
Neuropathy peripheral (surface nerve damage)
Platelet count decreased
Urinary tract infection
Cytomegalovirus test positive

male:

Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Cholecystitis (infection of gallbladder)
Osteonecrosis of jaw (death of bone of jaw)
Rib fracture
Cardiac failure congestive
Chest pain
Dyspnoea (difficult or laboured respiration)
Febrile neutropenia (fever with reduced white blood cells)

What are the common drug interactions of Maxipime and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pneumonia

50-59:

Malignant neoplasm progression (cancer tumour came back)
Pyrexia (fever)
Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Inappropriate antidiuretic hormone secretion
Nausea (feeling of having an urge to vomit)
Neck mass (mass in neck)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased

60+:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Benign neoplasm (benign (non-cancerous) tumour)
Pneumonia
Pyrexia (fever)
Diarrhoea
Platelet count decreased
Urinary tract infection
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Cholecystitis (infection of gallbladder)
Cytomegalovirus test positive

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 18 people, 81.82%
Fever: 6 people, 27.27%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 18.18%
Constipation: 4 people, 18.18%
Insomnia (sleeplessness): 4 people, 18.18%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 4 people, 18.18%
Neuropathy Peripheral (surface nerve damage): 3 people, 13.64%
Cytomegalovirus Infection: 3 people, 13.64%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 9.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Maxipime and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously